Reneo Pharmaceuticals
Reneo Pharmaceuticals is a Genetically-Defined Orphan Therapies.
2
Funding Rounds
$145.0m
Money raised
Overview
Reneo Pharmaceuticals is a Genetically-Defined Orphan Therapies.
-
Website:
- Business model: B2C
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Reneo Pharmaceuticals has raised a total of $145m in funding over 2 rounds.
Key Insights:
- Reneo Pharmaceuticals Series B round, December 2020: $95m
- Reneo Pharmaceuticals Series A round, May 2019: $50m
Reneo Pharmaceuticals Series B round, December 2020
$95m
Reneo Pharmaceuticals Series A round, May 2019
$50m
Industries
Reneo Pharmaceuticals is active in the following industries: